Oric Pharmaceuticals, Inc. ORIC Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Oric Pharmaceuticals, Inc.’s reported figures.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s invested capital?
- Oric Pharmaceuticals, Inc. (ORIC) reported invested capital of $362.46M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Oric Pharmaceuticals, Inc.'s invested capital increased by 108.8% year-over-year, from $173.62M to $362.46M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s invested capital has grown at a 55.4% compound annual growth rate (CAGR), from $59.41M to $346.13M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).